141
U.S. FDA
right page (141)
of ONYX SL91 FCC am (11.09.2006, 11:58)
Ben
Q
2006, Z:\SL
91_ONYX\ou
tput
\FUG\ON
YX_FCC_am_060911_t
e\FM\
STD_FDA
_
FCC_am.fm
Te
m
p
lat
e: Minion
, 140x105 mm, Ve
rsi
o
n 2.0;
VAR Language: am;
VAR issue
date: 060711
Where can I find additional informa-
tion?
For additional information, see the
following websites:
• Federal Communications Commis-
sion (FCC) RF Safety Program (select
“Information on Human Exposure to
RF Fields from Cellular and PCS Ra-
dio Transmitters”):
www.fcc.gov/oet/rfsafety
• World Health Organization (WHO)
International Commission on Non-
Ionizing Radiation Protection (select
Qs & As):
www.who.int/emf
• United Kingdom, National Radiolog-
ical Protection Board:
www.nrpb.org.uk
• Cellular Telecommunications Indus-
try Association (CTIA):
www.wow-com.com
• U.S. Food and Drug Administration
(FDA) Center for devices and Radio-
logical Health:
www.fda.gov/cdhr/consumer/
1
Muscat et al. Epidemiological Study of
Cellular Telephone Use and Malignant
Brain Tumors. In: State of the Science Sym-
posium; 1999 June 20; Long Beach, Califor-
nia.
2
Tice et al. Tests of mobile phone signals
for activity in genotoxicity and other labo-
ratory assays. In: Annual Meeting of the En-
vironmental Mutagen Society; March 29,
1999, Washington, DC; and personal com-
munication, unpublished results.
3
Preece, AW, Iwi, G, Davies-Smith, A,
Wesnes, K, Butler, S, Lim, E, and Varey, A.
Effect of a 915- MHz simulated mobile
phone signal on cognitive function in man.
Int. J. Radiat. Biol., April 8, 1999.
4
Hardell, L, Nasman, A, Pahlson, A, Hal-
lquist, A and Mild, KH. Use of cellular tele-
phones and the risk for brain tumors;
a case-control study. Int. J. Oncol, 15:
113-116, 1999.
